[Dysfunctional uterine bleeding. Hormonal management with chlormadinone acetate].
In 138 patients with uterine dysfunctional bleeding a hormonal treatment with chlormadinone acetate, was given. The dosage varied according to four therapeutic stages: hemostatic, maintenance, consolidation and observation. Patients were placed in three groups: Group I, adolescents, Group II, reproductive life, Group III, premenopausal. In 51.9% of the patients there was endometrial hyperplasia, proliferative in 26.6% and secretory in 14.1%. Good results were obtained in all four therapeutic stages.
D000328:Adult; D002715:Chlormadinone Acetate / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008598:Menstruation / Q000187:drug effects; D008599:Menstruation Disturbances / Q000188:drug therapy*; D008875:Middle Aged; D011247:Pregnancy; D013997:Time Factors; D014592:Uterine Hemorrhage / Q000188:drug therapy*
D002715:Chlormadinone Acetate
Sangrado uterino disfunctional. Manejo hormonal con acetato de clormadinona.